Preclinical News and Research

RSS
Spherix 2011 net loss decreases to $3.5 million

Spherix 2011 net loss decreases to $3.5 million

Imatinib improves RFS, overall survival in GIST patients after surgery

Imatinib improves RFS, overall survival in GIST patients after surgery

New pre-clinical data on Rexahn's RX-3117 study to be presented at AACR meeting

New pre-clinical data on Rexahn's RX-3117 study to be presented at AACR meeting

Pfizer to present data on ADCs at AACR 2012

Pfizer to present data on ADCs at AACR 2012

Hapten licenses HPT-721 to prevent poison ivy dermatitis

Hapten licenses HPT-721 to prevent poison ivy dermatitis

Synthetic pasta-like objects are major chemistry advances for regenerative medicine

Synthetic pasta-like objects are major chemistry advances for regenerative medicine

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

GenVec announces data from respiratory syncytial virus vaccine program

GenVec announces data from respiratory syncytial virus vaccine program

China SFDA approves Taibang's clinical trials for human fibrinogen

China SFDA approves Taibang's clinical trials for human fibrinogen

Immediate skull reconstruction aggravates brain damage in TBI model

Immediate skull reconstruction aggravates brain damage in TBI model

Opioids may influence breast cancer survival

Opioids may influence breast cancer survival

Study shows how to defeat chemotherapy barrier in pancreatic cancer

Study shows how to defeat chemotherapy barrier in pancreatic cancer

TACT believes that Halo's HT-100 may effectively treat DMD

TACT believes that Halo's HT-100 may effectively treat DMD

DIAN-TTU to receive $4.2M Alzheimer's Association research grant

DIAN-TTU to receive $4.2M Alzheimer's Association research grant

Thermedical closes $1.5 million in Series A funding

Thermedical closes $1.5 million in Series A funding

ISCO fourth quarter revenue increases 110% to $1.1 million

ISCO fourth quarter revenue increases 110% to $1.1 million

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer

Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer

Positive data from XENTION's XEN-D0103 phase 1 trial on AF

Positive data from XENTION's XEN-D0103 phase 1 trial on AF

New antibiotic shows promise against bovine mastitis

New antibiotic shows promise against bovine mastitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.